* Enovis Corp ENOV.N reported quarterly adjusted earnings
of 50
cents per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of 44
cents. The mean expectation of ten analysts for the quarter was
for earnings of 48 cents per share. Wall Street expected
results to range from 38 cents to 54 cents per share.
* Revenue rose 27.1% to $516.27 million from a year ago;
analysts
expected $503.90 million.
* Enovis Corp's reported EPS for the quarter was a loss of
$1.32.
* The company reported a quarterly loss of $72 million.
* Enovis Corp shares had fallen by 11.3% this quarter and
lost 1.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 22%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Enovis Corp is
$75.00
This summary was machine generated from LSEG data May 2 at 07:46
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 0.48 0.50 Beat
Dec. 31 2023 0.74 0.79 Beat
Sep. 30 2023 0.54 0.56 Beat
Jun. 30 2023 0.52 0.61 Beat